tricalcium phosphate has been researched along with Hepatitis B in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dittmer, U; Du, Y; Epple, M; Han, M; Li, J; Lu, M; Sokolova, V; Wey, K; Wu, J; Yan, H; Yang, D; Yang, X; Zou, S | 1 |
| Alvarez, MM; Chirigos, MA; Civantos, A; Peña, E; Sada, G; Sánchez, L; Villarrubia, VG | 1 |
| Elorza, FL; Herrerias, JM; Jimenez, M; Sada, G; Valladolid, JM; Vilchez, JG; Villarrubia, VG | 1 |
3 other study(ies) available for tricalcium phosphate and Hepatitis B
| Article | Year |
|---|---|
Delivery of toll-like receptor 3 ligand poly(I:C) to the liver by calcium phosphate nanoparticles conjugated with an F4/80 antibody exerts an anti-hepatitis B virus effect in a mouse model.
Topics: Animals; Antibodies; Calcium Phosphates; Drug Delivery Systems; Hepatitis B; Hepatitis B virus; Ligands; Liver; Mice; Nanoparticles; Poly I-C; Toll-Like Receptor 3 | 2021 |
AM3, an adjuvant to hepatitis B revaccination in non-responder healthy persons.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Antibody Formation; Calcium Phosphates; Child; Child, Preschool; Glycopeptides; Hepatitis B; Humans; Immunologic Factors; Infant; Middle Aged; Vaccination | 1995 |
Therapeutic response of chronic active hepatitis B (CAHB) to a new immunomodulator: AM3. Immunohematological effects.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Antiviral Agents; Calcium Phosphates; Female; Glycopeptides; Hepatitis B; Hepatitis, Chronic; Humans; Lymphocyte Subsets; Male; Middle Aged | 1992 |